CFTR and cystic fibrosis: This figure shows the therapeutic targets of CF, CFTR modulators (potentiators, correctors, and amplifiers), epithelial sodium channel (ENaC) inhibitors, calcium-activated anion channel agents (ANO1, ANO6: Anoctamino O1, O6) read-through, RNA therapy and editing and therapy genes.